Fortress Biotech Inc.

0.8229-0.0355-4.14%Vol 166.75K1Y Perf -76.99%
Jun 28th, 2022 16:00 DELAYED
BID0.8200 ASK0.8500
Open0.8500 Previous Close0.8584
Pre-Market- After-Market0.85
 - -  0.03 3.29%
Target Price
9.42 
Analyst Rating
Strong Buy 1.00
Potential %
1.04K 
Finscreener Ranking
★★★★★     61.93
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     50.13
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     52.69
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.71 
Earnings Rating
Neutral
Market Cap88.39M 
Earnings Date
15th Aug 2022
Alpha-0.02 Standard Deviation0.27
Beta2.27 

Today's Price Range

0.82200.8600

52W Range

0.77103.81

5 Year PE Ratio Range

-3.70-1.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
2.35%
1 Month
-4.66%
3 Months
-39.55%
6 Months
-64.67%
1 Year
-76.99%
3 Years
-42.77%
5 Years
-82.48%
10 Years
-82.59%

TickerPriceChg.Chg.%
FBIO0.8229-0.0355-4.14
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
3.10
3.30
0.53
1.21
-15.40
Leverage Ratio 4.00
ProfitabilityValueIndustryS&P 500US Markets
53.70
-217.30
-208.20
-282.90
-
RevenueValueIndustryS&P 500US Markets
81.13M
0.76
22.07
-6.86
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.28-0.1835.71
Q04 20210.10-0.38-480.00
Q03 2021-0.08-0.26-225.00
Q02 2021-0.14-0.0471.43
Q01 2021-0.17-0.1135.29
Q04 2020-0.18-0.0666.67
Q03 2020-0.28-0.2028.57
Q02 2020-0.28-0.1932.14
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.1739.29Positive
9/2022 QR-0.19-116.10Negative
12/2022 FY-0.77--
12/2023 FY0.04--
Next Report Date15th Aug 2022
Estimated EPS Next Report-0.17
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume166.75K
Shares Outstanding107.41K
Shares Float78.92M
Trades Count1.32K
Dollar Volume140.09K
Avg. Volume1.19M
Avg. Weekly Volume1.94M
Avg. Monthly Volume886.69K
Avg. Quarterly Volume729.82K

Fortress Biotech Inc. (NASDAQ: FBIO) stock closed at 0.8584 per share at the end of the most recent trading day (a -2.76% change compared to the prior day closing price) with a volume of 625.68K shares and market capitalization of 88.39M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 93 people. Fortress Biotech Inc. CEO is Lindsay A. Rosenwald.

The one-year performance of Fortress Biotech Inc. stock is -76.99%, while year-to-date (YTD) performance is -65.66%. FBIO stock has a five-year performance of -82.48%. Its 52-week range is between 0.771 and 3.81, which gives FBIO stock a 52-week price range ratio of 1.71%

Fortress Biotech Inc. currently has a PE ratio of -1.00, a price-to-book (PB) ratio of 0.97, a price-to-sale (PS) ratio of 1.14, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -18.44%, a ROC of -29.64% and a ROE of -72.42%. The company’s profit margin is -%, its EBITDA margin is -208.20%, and its revenue ttm is $81.13 Million , which makes it $0.76 revenue per share.

Of the last four earnings reports from Fortress Biotech Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.17 for the next earnings report. Fortress Biotech Inc.’s next earnings report date is 15th Aug 2022.

The consensus rating of Wall Street analysts for Fortress Biotech Inc. is Strong Buy (1), with a target price of $9.42, which is +1 044.73% compared to the current price. The earnings rating for Fortress Biotech Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fortress Biotech Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fortress Biotech Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.79, ATR14 : 0.10, CCI20 : -61.96, Chaikin Money Flow : -0.34, MACD : -0.02, Money Flow Index : 25.46, ROC : -18.25, RSI : 45.36, STOCH (14,3) : 20.14, STOCH RSI : 0.49, UO : 37.67, Williams %R : -79.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fortress Biotech Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

CEO: Lindsay A. Rosenwald

Telephone: +1 781 652-4500

Address: 2 Gansevoort Street, New York 10014, NY, US

Number of employees: 93

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

53%47%

Bearish Bullish

57%43%

TipRanks News for FBIO

Sun, 22 May 2022 12:26 GMT Fortress Biotech (FBIO) Receives a Buy from Dawson James

- TipRanks. All rights reserved.

Mon, 18 Apr 2022 11:35 GMT Fortress Biotech (FBIO) Gets a Buy Rating from B.Riley Financial

- TipRanks. All rights reserved.

Mon, 28 Mar 2022 15:35 GMT Analysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO), Venus Concept (VERO) and IN8bio (INAB)

- TipRanks. All rights reserved.

Wed, 05 Jan 2022 09:05 GMT Analysts Offer Insights on Healthcare Companies: and Fortress Biotech (FBIO)

- TipRanks. All rights reserved.

News

Stocktwits